Role of CREB in the regulatory action of sarsasapogenin on muscarinic M1 receptor density during cell aging (Q38345937)

2 September 2017

title

Role of CREB in the regulatory action of sarsasapogenin on muscarinic M1 receptor density during cell aging (English)

1 reference

2 September 2017

Haiyan Hu

1

1 reference

2 September 2017

Rui Zhang

2

1 reference

2 September 2017

Yongfang Zhang

3

1 reference

2 September 2017

Zongqin Xia

4

1 reference

2 September 2017

Yaer Hu

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

6 March 2010

1 reference

2 September 2017

1 reference

2 September 2017

volume

584

1 reference

2 September 2017

issue

8

1 reference

2 September 2017

page(s)

1549-1552

1 reference

Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Disruption of CREB function in brain leads to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Phosphorylated CREB binds specifically to the nuclear protein CBP

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Structure of the m1 muscarinic acetylcholine receptor gene and its promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Identification and characterization of the rat M1 muscarinic receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

ATF4-dependent oxidative induction of the DNA repair enzyme Ape1 counteracts arsenite cytotoxicity and suppresses arsenite-mediated mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

AP-1 in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Antisense oligodeoxynucleotide-mediated disruption of hippocampal cAMP response element binding protein levels impairs consolidation of memory for water maze training

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Antisense technologies. Improvement through novel chemical modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Molecular and cellular mechanisms of memory allocation in neuronetworks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Target profiling of small molecules by chemical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

The expanding role of BDNF: a therapeutic target for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.03.006

10.1016/J.FEBSLET.2010.03.006

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference